Abstract
This is an update to the AAN guideline for the use of botulinum neurotoxins in treatment of neurologic disorders. Many advances have occurred since the previous guidelines, published in 2008. The outline of evidence for the 4 approved formulations in the US is a very useful resource for practitioners. This is a great update to an essential resource for practitioners.